Making a difference in clinical trials: The impact of engagement
We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all.
Search
Embracing diversity in clinical trials: A global mandate
Have you ever wondered why medicines work differently for different people? Each patient is unique. By embracing diversity in clinical trials, we enable more equitable and inclusive healthcare.
Clinical Studies
Clinical Studies
Oncology Translational Science
Discover how Boehringer Ingelheim leverages translational science to bridge pre-clinical research and clinical development, enhancing patient outcomes in oncology. Learn about our patient-centric strategies, biomarker discovery, and collaborative efforts
Data Science: Revolutionizing research and development with data driven insights
Using data in pharmaceutical research to better address patient needs
Boehringer Ingelheim_Five ways to include more diversity in clinical trials
Drug discovery Boehringer Ingelheim
Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.
Vaccines
Vaccines
Retinal Diseases
Retinal Diseases
Data Privacy-video surveillance at Boehringer Ingelheim
Data Protection Notice for video surveillance
Data Protection Notice Members Healthcare Professions
Data Protection Notice Members Healthcare Professions
Solidarity with Ukraine
Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term with monetary and in kind donations.
Patient Safety & Pharmacovigilance at Boehringer Ingelheim
Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.
Data Protection Notice Medical Inquiries
Data Protection Notice Medical Inquiries
Data Privacy-Pharmacovigilance in Animal Health
Data Privacy Notice for Pharmacovigilance in Animal Health
Data Privacy-Pharmacovigilance Humanpharma
Mental Health
Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases.
Boehringer Ingelheim Office Hours
Boehringer Ingelheim Office Hours
Innovation in Oncology and Cancer Immunology Research
We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
Interstitial Lung Diseases - Sound the ILD Alarm
Learn more about ILDs and why it's important to ‘sound the ILD alarm’ for early detection and treatment.
Women in STEM: Passion for science to achieve more sustainable healthcare solutions
Women in STEM: Passion for science to achieve more sustainable healthcare solutions
Improving Access to Healthcare
According to the UN Sustainable Development Goals, nearly half of the world's population lacks access to basic health care.
Data Privacy Notice for Customers, Partners, Visitors, Distributors and interested Persons
Data Privacy Notice for Customers, Partners, Visitors, Distributors and interested Persons
Data Protection Notice for Members of Healthcare Professions in Animal Health
Data Protection Notice for Members of Healthcare Professions in Animal Health
Venture Fund searching for groundbreaking trends
The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.